Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 14147L108 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
| BlackRock, Inc. 13G/A Amendment 1 | 1.3% |
7/27/2026
Event 6/30/2026
|
|
| Vanguard Group Inc 13G/A Amendment 1 | 0% |
3/26/2026
Event 3/13/2026
|
|
|
Commodore Capital LP
13G/A
Amendment 1
|
0% |
8/14/2025
Event 6/30/2025
|
|
| Commodore Capital LP | 0% | ||
| Commodore Capital Master LP | 0% | ||
| Vanguard Group Inc 13G | 5.6% |
7/29/2025
Event 6/30/2025
|
|
| BlackRock, Inc. 13G | 5.8% |
4/23/2025
Event 3/31/2025
|
|
| Pfizer Inc 13G/A Amendment 1 | 3.6% |
2/12/2025
Event 12/31/2024
|
|
| BlackRock, Inc. 13G/A Amendment 1 | 4.3% |
2/5/2025
Event 12/31/2024
|
|
|
Commodore Capital LP
13G
|
8.1% |
12/17/2024
Event 12/10/2024
|
|
| Commodore Capital LP | 8.1% | ||
| Commodore Capital Master LP | 8.1% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 5 | 739 k | $894 k |
| 2026 Q2 | 109 | 18.8 M | $24.3 M |
| 2026 Q1 | 120 | 24.6 M | $39.7 M |
| 2025 Q4 | 115 | 27.2 M | $76.6 M |
| 2025 Q3 | 122 | 25.2 M | $52.2 M |
| 2025 Q2 | 126 | 28.9 M | $90.9 M |
| 2025 Q1 | 126 | 32.4 M | $102 M |
| 2024 Q4 | 128 | 29.5 M | $128 M |
| 2024 Q3 | 92 | 12.8 M | $34.1 M |
| 2024 Q2 | 101 | 13.7 M | $30.4 M |
| 2024 Q1 | 88 | 8.80 M | $46.9 M |
| 2023 Q4 | 63 | 5.33 M | $7.88 M |
| 2023 Q3 | 62 | 5.46 M | $7.58 M |
| 2023 Q2 | 55 | 5.99 M | $8.81 M |
| 2023 Q1 | 59 | 7.05 M | $11.6 M |
| 2022 Q4 | 67 | 7.84 M | $11.0 M |
| 2022 Q3 | 65 | 7.93 M | $12.2 M |
| 2022 Q2 | 73 | 8.93 M | $19.6 M |
| 2022 Q1 | 98 | 16.5 M | $41.0 M |
| 2021 Q4 | 97 | 22.3 M | $134 M |
| 2021 Q3 | 104 | 21.1 M | $141 M |
| 2021 Q2 | 99 | 26.5 M | $176 M |
| 2021 Q1 | 85 | 24.1 M | $223 M |
| 2020 Q4 | 98 | 26.9 M | $484 M |
| 2020 Q3 | 78 | 18.7 M | $266 M |
| 2020 Q2 | 32 | 4.98 M | $25.0 M |